Table 3 Unadjusted screening performance measurements
Total | Group 1 | Group 2 | Group 3 | Group 4 | Group 5 | |
|---|---|---|---|---|---|---|
Recall/1000 | 22.8 | 25.0 | 20.5 | 22.3 | 21.8 | 24.3 |
False positives/1000 | 16.5 | 18.4 | 14.3 | 15.2 | 16.1 | 18.6 |
Screen-detected cancers/1000 | 6.3 | 6.7 | 6.2 | 7.1 | 5.7 | 5.7 |
Interval cancers/1000 | 2.0 | 1.4 | 1.8 | 1.8 | 2.5 | 2.7 |
Program sensitivity (%) | 75.6 | 82.7 | 77.4 | 79.7 | 70.0 | 68.2 |
12-month sensitivity (%) | 88.3 | 90.3 | 91.6 | 93.5 | 85.4 | 80.4 |
Specificity (%) | 98.3 | 98.2 | 98.6 | 98.5 | 98.4 | 98.1 |
Positive predictive value (%) | 27.5 | 26.7 | 30.1 | 31.8 | 26.3 | 23.5 |